Concepedia
Statistics
Publications
5
Citations
172
H-Index
Active since
2005
Affiliations
Pfizer (United States)(Current)
Harvard University
Center For Policy Research
Tamer Abdelgawad is an author at Pfizer (United States) specializing in public health, medicine, and health policy.
Top concepts
MedicineHealth PolicyPublic HealthOncologyCancer ResearchHealth CoveragePharmacotherapyOutcomes ResearchHealth Services ResearchManaged Care
Publications per year
2005–2020
The Large Social Value Resulting From Use Of Statins Warrants Steps To Improve Adherence And Broaden Treatment
David C. Grabowski, Darius Lakdawalla, Dana P. Goldman et al. · Health Affairs · 2012 · 57 citations
New Anticancer Drugs Associated With Large Increases In Costs And Life Expectancy
David H. Howard, Michael E. Chernew, Tamer Abdelgawad et al. · Health Affairs · 2016 · 43 citations · Full text
Cancer Management, Epidemiology Of Cancer, Pharmacotherapy +21
The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force.
Humaid O. Al‐Shamsi, Humaa Darr, Ibrahim Abu-Gheida et al. · PubMed · 2020 · 33 citations
Oncology, Cancer Epidemiology, Health Policy +15
Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to Medicaid.
Matthew M. Murawski, Tamer Abdelgawad · PubMed · 2005 · 25 citations
Preferred Drug Lists and Medicaid Prescriptions
Tamer Abdelgawad, Lisa Egbuonu‐Davis · PharmacoEconomics · 2006 · 14 citations
Preferred Drug Lists, Preventive Medicine, Health Policy +8
1–5 of 5